Loading

XtalPi

June 16, 2025
Company Presentation
Tools/Drug Development Support Tech
XtalPi is a pioneering technology company reshaping drug discovery through an integrated platform that leverages AI, automation, and advanced digital tools. The company accelerates the research and development of new therapeutics by harnessing cutting-edge computational models and machine learning to optimize every stage of the drug discovery process. XtalPi’s platform delivers high-precision predictions for molecular behavior, streamlines drug candidate optimization, and shortens timelines, all while reducing costs. By integrating AI-driven insights and automation, XtalPi enables pharmaceutical companies and research institutions to overcome traditional barriers in drug development and bring novel therapies to market faster. With a focus on innovation and efficiency, XtalPi is at the forefront of transforming the pharmaceutical landscape, driving breakthroughs in drug discovery and development.
XtalPi
Company HQ City: Cambridge
Company HQ State: Massachusetts
Company HQ Country: United States
Year Founded: 2014
Lead Product in Development: Digital and automation tools (not a biotech or pharma)

CEO

Dr. Jian Ma

Year Founded

2014

Development Phase of Lead Product

Other/Not Applicable

Exchange

Hong Kong

Ticker

2228

When you expect your next catalyst update?

N/A

What is your next catalyst (value inflection) update?

N/A

Website

xtalpi.com
Primary Speaker
Sarah Trice
Sarah Trice, PhD
COO, Head of US Operations
XtalPi

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS